Moving ahead on harnessing synthetic lethality to fight cancer

被引：1
|
作者：
Jerby-Arnon, Livnat [1 ]
Ruppin, Eytan [1 ,2 ]
机构：
[1] Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2015年 / 2卷 / 02期
关键词：
synthetic lethality; genetic interactions; cancer genomics; precision medicine;
D O I：
10.4161/23723556.2014.977150
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We have recently developed a data-mining pipeline that comprehensively identifies cancer unique susceptibilities, following the concept of Synthetic Lethality (SL). The approach enables, for the first time, to identify and harness genome-scale SL-networks to accurately predict gene essentiality, drug response, and clinical prognosis in cancer.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Harnessing synthetic lethality to predict the response to cancer treatment
    Lee, Joo Sang
    Das, Avinash
    Jerby-Arnon, Livnat
    Arafeh, Rand
    Auslander, Noam
    Davidson, Matthew
    McGarry, Lynn
    James, Daniel
    Amzallag, Arnaud
    Park, Seung Gu
    Cheng, Kuoyuan
    Robinson, Welles
    Atias, Dikla
    Stossel, Chani
    Buzhor, Ella
    Stein, Gidi
    Waterfall, Joshua J.
    Meltzer, Paul S.
    Golan, Talia
    Hannenhalli, Sridhar
    Gottlieb, Eyal
    Benes, Cyril H.
    Samuels, Yardena
    Shanks, Emma
    Ruppin, Eytan
    NATURE COMMUNICATIONS, 2018, 9
  • [2] Harnessing synthetic lethality to predict the response to cancer treatment
    Joo Sang Lee
    Avinash Das
    Livnat Jerby-Arnon
    Rand Arafeh
    Noam Auslander
    Matthew Davidson
    Lynn McGarry
    Daniel James
    Arnaud Amzallag
    Seung Gu Park
    Kuoyuan Cheng
    Welles Robinson
    Dikla Atias
    Chani Stossel
    Ella Buzhor
    Gidi Stein
    Joshua J. Waterfall
    Paul S. Meltzer
    Talia Golan
    Sridhar Hannenhalli
    Eyal Gottlieb
    Cyril H. Benes
    Yardena Samuels
    Emma Shanks
    Eytan Ruppin
    Nature Communications, 9
  • [3] Harnessing synthetic lethality to predict the response to cancer treatments
    Lee, Joo S.
    Das, Avinash
    Jerby-Arnon, Livnat
    Arafeh, Rand
    Davidson, Matthew
    Amzallag, Arnaud
    Park, Seung Gu
    Cheng, Kuoyuan
    Robinson, Welles
    Atias, Dikla
    Stossel, Chani
    Buzhor, Ella
    Stein, Gidi
    Waterfall, Joshua J.
    Meltzer, Paul S.
    Golan, Talia
    Hannenhalli, Sridhar
    Gottlieb, Eyal
    Benes, Cyril H.
    Samuels, Yardena
    Shanks, Emma
    Ruppin, Eytan
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [4] Harnessing synthetic lethality to predict clinical outcomes of cancer treatment
    Lee, Joo Sang
    Das, Avinash
    Jerby-Arnon, Livnat
    Atias, Dikla
    Amzallag, Arnaud
    Benes, Cyril H.
    Golan, Talia
    Ruppin, Eytan
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (10)
  • [5] Harnessing synthetic lethality to predict clinical outcomes of cancer treatment
    Lee, Joo Sang
    Das, Avinash
    Jerby-Arnon, Livnat
    Park, Seung Gu
    Davidson, Matthew
    Atias, Dikla
    Amzallag, Arnaud
    Stossel, Chani
    Buzhor, Ella
    Robinson, Welles
    Cheng, Kuoyuan
    Waterfall, Joshua J.
    Meltzer, Paul S.
    Hannenhalli, Sridhar
    Benes, Cyril H.
    Golan, Talia
    Shanks, Emma
    Ruppin, Eytan
    CANCER RESEARCH, 2017, 77
  • [6] Synthetic lethality and cancer
    O'Neil, Nigel J.
    Bailey, Melanie L.
    Hieter, Philip
    NATURE REVIEWS GENETICS, 2017, 18 (10) : 613 - 623
  • [7] Synthetic lethality and cancer
    Nigel J. O'Neil
    Melanie L. Bailey
    Philip Hieter
    Nature Reviews Genetics, 2017, 18 : 613 - 623
  • [8] Harnessing the influenza virus to fight cancer
    Ji, Dezhong
    NATURE REVIEWS CANCER, 2024, 24 (01) : 1 - 1
  • [9] Harnessing the influenza virus to fight cancer
    Dezhong Ji
    Nature Reviews Cancer, 2024, 24 : 1 - 1
  • [10] Synthetic lethality: Killing cancer with cancer
    Garber, K
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (22) : 1666 - 1668
12345